UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063517
Receipt number R000072529
Scientific Title Scheduled intraoperative repeated skin lavage with dilute povidone-iodine for suppression of Cutibacterium acnes re-emergence during arthroscopic shoulder surgery: a randomized controlled trial, with a nested serum testosterone substudy. RIPPLE study (Repeated Intraoperative Povidone-Iodine Protocol for Lavage Efficacy)
Date of disclosure of the study information 2026/11/17
Last modified on 2026/11/12 21:30:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Repeated skin lavage with dilute povidone-iodine during arthroscopic shoulder surgery to prevent Cutibacterium acnes re-emergence, with a serum testosterone substudy

Acronym

RIPPLE study

Scientific Title

Scheduled intraoperative repeated skin lavage with dilute povidone-iodine for suppression of Cutibacterium acnes re-emergence during arthroscopic shoulder surgery: a randomized controlled trial, with a nested serum testosterone substudy. RIPPLE study (Repeated Intraoperative Povidone-Iodine Protocol for Lavage Efficacy)

Scientific Title:Acronym

RIPPLE study

Region

Japan


Condition

Condition

Patients undergoing arthroscopic rotator cuff repair or arthroscopic Bankart repair (rotator cuff tear, anterior shoulder instability)

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether repeated intraoperative skin lavage with 0.35% dilute povidone-iodine at 30-minute intervals after standard surgical skin preparation reduces Cutibacterium acnes (C. acnes) culture positivity immediately before wound closure during arthroscopic shoulder surgery. This randomized controlled trial also includes two nested substudies: evaluation of C. acnes re-emergence approximately 60 minutes after skin preparation and investigation of the association between preoperative serum total testosterone levels and shoulder skin C. acnes burden, primarily in male patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Cutibacterium acnes culture positivity rate in shoulder skin swab samples collected immediately before wound closure (before initiation of suturing, Tclosure), compared between the control group and the repeated 0.35% dilute povidone-iodine lavage group.

Key secondary outcomes

1. C. acnes culture positivity rates before skin preparation (T0) and immediately after skin preparation (T1).
2. C. acnes culture conversion from negative at T1 to positive immediately before wound closure (Tclosure).
3. Semiquantitative C. acnes burden (negative, 1+, 2+, 3+) at T0, T1, approximately 60 minutes after skin preparation (T60), and Tclosure, including changes over time.
4. Association between the time interval (minutes) from completion of the last lavage to culture sampling at Tclosure and C. acnes positivity in the lavage group. In the control group, the interval from completion of skin preparation to Tclosure will be evaluated.
5. Comparison of C. acnes culture positivity rates and semiquantitative bacterial burden at T60 (immediately before the second lavage in the intervention group) between groups.
6. Association between preoperative serum total testosterone levels and baseline (T0) semiquantitative C. acnes burden in male patients.
7. Exploratory associations of serum total testosterone levels with C. acnes burden and culture positivity at T60 and Tclosure, effect modification of repeated lavage, sex-related differences, and prediction of C. acnes culture positivity at wound closure.
8. Postoperative wound complications within 30 days after surgery.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Control group (Group A): Standard surgical skin preparation with alcohol-based 10% povidone-iodine (PVP-I-ALC) is performed during arthroscopic shoulder surgery. No additional intraoperative skin lavage is performed. The intervention period is limited to a single surgical procedure. Skin swab samples for C. acnes culture are collected before skin preparation (T0), immediately after skin preparation (T1), approximately 60 minutes after skin preparation (T60, if eligible), and immediately before wound closure (Tclosure).

Interventions/Control_2

Repeated lavage group (Group B): Following standard surgical skin preparation with alcohol-based 10% povidone-iodine (PVP-I-ALC), repeated intraoperative skin lavage with 0.35% dilute povidone-iodine is performed. The first lavage is performed 30 minutes after completion of skin preparation, followed by repeated lavage every 30 minutes after completion of the preceding lavage. Approximately 200 mL of 0.35% dilute povidone-iodine is applied to the entire shoulder skin surface using a 50-mL irrigation syringe four times over approximately 15 seconds per lavage, without wiping. Lavage is repeated until suturing begins. The intervention period is limited to a single surgical procedure. Skin swab samples for C. acnes culture are collected before skin preparation (T0), immediately after skin preparation (T1), immediately before the second lavage (T60, if eligible), and immediately before wound closure (Tclosure).

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients scheduled to undergo elective primary arthroscopic rotator cuff repair (ARCR) or arthroscopic Bankart repair (ABR).
2. No restrictions on age or sex.
3. Patients who have not declined participation in the study.

Key exclusion criteria

1. Active infection of the operative shoulder, surgery for infection, or a history of previous surgery on the ipsilateral shoulder.
2. Active skin disease or skin damage at the operative site.
3. Known hypersensitivity to povidone-iodine (iodine) or alcohol.
4. Systemic antibiotic treatment within 2 weeks before surgery, excluding perioperative prophylactic antibiotics.
5. Preoperative skin decolonization treatment targeting C. acnes, including topical benzoyl peroxide (BPO).
6. Any other condition considered unsuitable for participation by the principal investigator.

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Kamijo

Organization

Funabashi Orthopaedic Hospital

Division name

Shoulder & Elbow Service, Sports Medicine & Joint Center

Zip code

274-0822

Address

1-845 Hasama Funabashi, Chiba

TEL

09034381126

Email

hkamijyo@fff.or.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Kamijo

Organization

Funabashi Orthopaedic Hospital

Division name

Sports Medicine & Joint Center

Zip code

274-0822

Address

1-845 Hasama Funabashi, Chiba

TEL

047-425-5585

Homepage URL


Email

hideki_kamijou@yahoo.co.jp


Sponsor or person

Institute

Funabashi Orthopaedic Hospital

Institute

Department

Personal name



Funding Source

Organization

Funabashi Orthopaedic Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Funabashi Orthopaedic Hospital

Address

1-845 Hasama Funabashi, Chiba

Tel

047-425-5585

Email

rinri@fff.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

船橋整形外科病院(千葉県)


Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 01 Day

Date of IRB

2026 Year 10 Month 31 Day

Anticipated trial start date

2026 Year 12 Month 01 Day

Last follow-up date

2027 Year 06 Month 30 Day

Date of closure to data entry

2027 Year 07 Month 15 Day

Date trial data considered complete

2027 Year 07 Month 31 Day

Date analysis concluded

2027 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2026 Year 11 Month 04 Day

Last modified on

2026 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072529